STAT3 and graft versus host disease: In a major histocompatibility complex–mismatched mouse model of severe GVHD, the authors demonstrated protection from GVHD with Stat3-deficient T cells, but only in the presence of intact programmed death-ligand 1/programmed cell death protein 1 (PD-L1/PD-1) signaling.